Skip to menu Skip to content Skip to footer

SerpenSeal, next generation wound management (2025-2026)

Abstract

This project will develop an Indigenous manufactured Spinifex gel in combination with snake venom or bleeding control, SerpenSeal. Enabling capabilities for additive manufacturing with Indigenous Australian industry partner Bulugudu Ltd. to establish both a quality controlled scalable production pipeline of the Spinifex derived nanocellulose, the base material for application to control both surgical and more profuse traumatic bleeding. Progressing development of this innovative concept, from TRL3 to TRL4, facilitating the translation and commercialisation of Australia's cutting-edge research, envisaged to surpass the therapeutic functionality and quality of current healthcare products.

Experts

Professor Alan Rowan

Affiliate of Centre for Extracellular Vesicle Nanomedicine
Centre for Extracellular Vesicle Nanomedicine
Faculty of Health, Medicine and Behavioural Sciences
Executive Institute Director, Australian Institute for Bioengineering and Nanotechnology
Office of the Provost
Alan Rowan
Alan Rowan

Dr Amanda Kijas

Senior Research Fellow
Australian Institute for Bioengineering and Nanotechnology
Amanda Kijas
Amanda Kijas

Professor Mark Midwinter

Affiliate of Centre for Motor Neuron Disease Research
Centre for Motor Neuron Disease Research
Faculty of Health, Medicine and Behavioural Sciences
Affiliate of Centre for Cardiovascular Health and Research
Centre for Cardiovascular Health and Research
Faculty of Health, Medicine and Behavioural Sciences
Professor
School of Biomedical Sciences
Faculty of Health, Medicine and Behavioural Sciences
Mark Midwinter
Mark Midwinter